Mechanistically, this advantage was dependent on the RAC1P29S-mediated assembly of a dendritic actin network and lamellipodia formation, which sequestered and inactivated the tumour suppressor (and RAS inactivator) NF2/Merlin, independent of the focal adhesion and MAPK signalling. Here, NF2 is linked to neoplasm.